GPC5 and metastatic melanoma: Recent bioinformatic analyses indicate that dysregulated expression of GPC5-AS1 is associated with several tumors, such as metastatic melanoma [21], renal cell cancer [22, 23], astrocytoma [24], and meningioma [25].